Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: A role for dual drug resistance?

被引：0
|
作者：
Lev, EI
Bray, PF
Patel, R
Delao, T
Granada, J
Kleiman, NS
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Methodist Hosp, Houston, TX 77030 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2005年 / 45卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：86A / 86A
页数：1
相关论文
共 50 条
  • [1] Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention - The role of dual drug resistance
    Lev, EI
    Patel, RT
    Maresh, KJ
    Guthikonda, S
    Granada, J
    DeLao, T
    Bray, PF
    Kleiman, NS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) : 27 - 33
  • [2] Resistance to antiplatelet drugs (aspirin, clopidogrel) in patients undergoing elective percutaneous coronary intervention
    Sulimov, V. A.
    Moroz, E. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2012, 8 (01) : 23 - 30
  • [3] Triflusal versus aspirin in conjunction with clopidogrel in patients undergoing percutaneous coronary intervention with drug-eluting stent
    Rha, Seung-Woon
    Kim, Hyun Hee
    Suh, Soon Yong
    Choi, Cheol Ung
    Kim, Jin Won
    Kim, Eung Ju
    Park, Chang Gyu
    Seo, Hong Seog
    Oh, Doug Joo
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (8A): : 205M - 205M
  • [4] Clopidogrel efficacy with concomitant drug therapy in patients undergoing percutaneous coronary intervention
    Alsalloum, Alhanouf S.
    Ibrahim, Tahani H.
    INTERNATIONAL JOURNAL OF ADVANCED AND APPLIED SCIENCES, 2020, 7 (09): : 35 - 42
  • [5] Aspirin resistance is associated with low response to clopidogrel after percutaneous coronary intervention: The clopidogrel and aspirin resistance evaluation in patients undergoing coronary revascularization (CARE-PCR) registry
    Park, Seong-Wook
    Park, Duk-Woo
    Suh, Jon
    Jung, In Hyun
    Kim, Sang Hyun
    Kim, Young-Halk
    Lee, Cheol Whan
    Hong, Myeong-Ki
    Kim, Jae-Joong
    Park, Seung-Jung
    CIRCULATION, 2006, 114 (18) : 813 - 813
  • [6] Triflusal versus aspirin in conjunction with clopidogrel in patients undergoing percutaneous coronary intervention with the drug-eluting stent.
    Rha, SW
    Suh, SY
    Kim, JW
    Park, CG
    Seo, HS
    Oh, DJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (8B): : 57D - 57D
  • [7] Significance of aspirin and clopidogrel resistance in patients undergoing percutaneous coronary interventions
    Pregowski, Jerzy
    Witkowski, Adam
    Sitkiewicz, Dariusz
    CURRENT VASCULAR PHARMACOLOGY, 2007, 5 (02) : 135 - 140
  • [8] Prevalence of aspirin and clopidogrel resistance in patients undergoing percutaneous coronary intervention: Comparison of triple versus dual anti platelet therapy
    Shim, Chi Young
    Yoon, Se-Jung
    Park, Sungha
    Ko, Ybung-Guk
    Choi, Donghoon
    Jang, Yangsoo
    Chung, Namsik
    Shim, Won-Heum
    Cho, Seung-Yun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 36B - 36B
  • [9] Clopidogrel plus indobufen in patients with hypersensitivity to aspirin undergoing percutaneous coronary intervention
    Barilla, F.
    Dominici, T.
    Pannarale, G.
    Giordano, F.
    Jacomelli, I.
    Pellicano, M.
    Sergi, S. C.
    Gaudio, C.
    Barilla, Francesco
    EUROPEAN HEART JOURNAL, 2012, 33 : 323 - 323
  • [10] Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention
    Buch, Ashesh N.
    Singh, Suman
    Roy, Probal
    Javaid, Aamir
    Smith, Kimberly A.
    George, Christopher E.
    Pichard, Augusto D.
    Satler, Lowell F.
    Kent, Kenneth M.
    Suddath, William O.
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (11): : 1518 - 1522
12345